Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function - A rebuttal [13]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 6, 2006, Pages 1429-1431

  Kratzer, Michael A A ^a,c   Kretschmer, V ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYZER; BLEEDING DISORDER; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TIME; BLOOD DONOR; BLOOD SAMPLING; BLOOD VISCOSITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HUMAN; LABORATORY TEST; LETTER; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE DISORDER; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION;

EID: 33646794952     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01976.x     Document Type: Letter

References (15)

1. Hayward CPM, Harrison P, Cattaneo M, Ortel TL, Rao AK on behalf of the Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Platelet function analyzer ((PFA)-100® closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4: 312-9.
2. Popper K. Logik der Forschung. Vienna, Austria: Julius Springer, 1935.
3. Born GVR, Kratzer MAA. Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J Physiol 1984; 354: 419-29.
4. Kratzer MAA, Born GVR. Simulation of primary haemostasis in vitro. Haemostasis 1985; 15: 357-62.
5. Kratzer MAA, Bellucci S, Caen JP. Detection of abnormal platelet functions with an in vitro model of primary haemostasis. Haemostasis 1985; 15: 363-70.
6. Kretschmer V, Schikor B, Sohngen D, Dietrich G. In vitro bleeding test a simple method for the detection of aspirin effects on platelet function. Thromb Res 1989; 56: 593-602.
7. Mammen EF, Rasheed SA, Philip CC. Preliminary data from a field trial of the PFA-100 system. Semin Thromb Hemost 1995; 21: 113-21.
8. Kundu SK, Heilmann EJ, Sio R, Garcia C, Ostgaard RA. Characterization of an in vitro platelet function analyzer - PFA-100. Clin Appl Thromb Hemost 1996; 2: 241-9.
9. Möller A, Weippert-Kretschmer M, Prinz H, Kretschmer V. Influence of ABO blood groups on primary hemostasis. Transfusion 2001; 41: 56-60.
10. Kretschmer V. Clinical implications of in vitro bleeding test - a review. Infusionsther Transfusionsmed 1997; 24: 428-34.
11. Kratzer MAA, Kretschmer V, Mammen EF, eds. Advances in methods for platelet function analysis. Semin Thromb Hemost 1995; 21: Suppl. 2.
12. Fressinaud E, Veyradier A, Truchaud F, Martin I, Boyer-Neumann C, Trossaert M, Meyer D. Screening for von Willebrand disease with a new analyzer using high shear stress: A study of 60 cases. Blood 1998; 91: 1325-31.
13. Kratzer MAA. Is primary haemostasis controlled by a platelet delay time? Formulation of a new hypothesis. Platelets 2003; 14: 437-43.
14. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
15. Koscielny J, Ziemer S, Radtke H, Schmutzler M, Pruss A, Sinha P, Salama A, Kiesewetter H, Latza R. A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10: 195-204.